SCHEMBL460113

SCHEMBL460113

COCC(N)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL4557069 0.97
SCHEMBL22151786 0.81
SCHEMBL27250224 0.75 HTT (0.46)
SCHEMBL18681521 0.75
SCHEMBL5036376 0.75
SCHEMBL18145167 0.73 HSD17B10 (0.38)
SCHEMBL17275381 0.73
SCHEMBL15879174 0.73
SCHEMBL22399151 0.73
SCHEMBL14738183 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118580024-A Anti-adsorption mud-blocking water reducer applicable to recycled coarse aggregate concrete and preparation thereof 同济大学 2024-09-03 CN claimed
CN-109603923-B Preparation method of catalytic cracking bimetallic passivator 山东益丰生化环保股份有限公司 2021-07-23 CN claimed
CN-111450901-A Preparation method of catalytic cracking metal passivator 山东巨展新材料有限公司 2020-07-28 CN claimed
CN-111153435-A Preparation method of antimony pentoxide crystal flame retardant 于淮旭 2020-05-15 CN claimed
CN-118580024-A Anti-adsorption mud-blocking water reducer applicable to recycled coarse aggregate concrete and preparation thereof 同济大学 2024-09-03 CN disclosed
US-20230285338-A9 METHODS FOR TREATING MICROGLIAL DYSFUNCTION WASHINGTON UNIVERSITY 2023-09-14 US disclosed
CN-115232074-A Synthesis method of 1-alkyl substituted-2-methyl-5-bromobenzimidazole 湖南复瑞生物医药技术有限责任公司 2022-10-25 CN disclosed
EP-4017282-A1 STABLE CREATINE BEVERAGES The Coca-Cola Company (US) 2022-06-29 EP disclosed
US-20210393563-A1 METHODS FOR TREATING MICROGLIAL DYSFUNCTION NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-12-23 US disclosed
CN-109603923-B Preparation method of catalytic cracking bimetallic passivator 山东益丰生化环保股份有限公司 2021-07-23 CN disclosed
US-11001569-B2 6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors JANSSEN PHARMACEUTICA NV (BE) 2021-05-11 US disclosed
CN-109311846-B Novel 6-membered heteroaromatic substituted cyanoindole derivatives as NIK inhibitors 杨森制药有限公司 2021-03-19 CN disclosed
WO-1997013507-A1 USE OF CREATINE ANALOGUES FOR THE TREATMENT OF DISORDERS OF GLUCOSE METABOLISM AVICENA GROUP, INC. (US) 1997-04-17 WO disclosed
US-5576316-A Method for inhibiting tumor growth rate using creatine or creatine analogs UNIVERSITY OF PENNSYLVANIA (US) 1996-11-19 US disclosed
WO-1996014063-A1 USE OF CREATINE OR CREATINE ANALOGS FOR THE TREATMENT OF DISEASES OF THE NERVOUS SYSTEM AVICENA GROUP, INC. (US) 1996-05-17 WO disclosed
WO-1994016687-A1 USE OF CREATINE OR ANALOGS FOR THE MANUFACTURE OF A MEDICAMENT FOR INHIBITING TUMOR GROWTH THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1994-08-04 WO disclosed
EP-0297605-B1 CELL CULTURE MICROCARRIERS MITSUBISHI KASEI CORPORATION (JP) 1992-10-21 EP disclosed
US-5006467-A Crosslinked copolymer of polyethylene glycol methacrylate and glycidyl methacrylate, recovering material produced by animal cells MITSUBISHI KASEI CORPORATION (JP) 1991-04-09 US disclosed
EP-0297605-A2 Cell culture microcarriers MITSUBISHI KASEI CORPORATION (JP) 1989-01-04 EP disclosed
US-4605419-A STRONG COLORATION ON OXIDATION SHISEIDO COMPANY LTD. (JP) 1986-08-12 US disclosed